Lisa A. DeRoo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lisa A. DeRoo has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Allen James Wilcox
Epidemiology Branch, Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Durham, NC
3 shared publications - Dale P. Sandler
Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Durham, NC, USA
3 shared publications - Jack A. Taylor
Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health (NIH), Research Triangle Park, Durham, NC 27709, USA
3 shared publications Beth A. Mueller
National Institute of Environmental Health Sciences 111 T. W. Alexander Drive P.O. Box 12233 A3-05 27709 Research Triangle Park MD NC
2 shared publicationsPeter Cummings
National Institute of Environmental Health Sciences 111 T. W. Alexander Drive P.O. Box 12233 A3-05 27709 Research Triangle Park MD NC
2 shared publications- Zongli Xu
Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, National Institutes of Health (NIH), Research Triangle Park, NC 27709, USA
2 shared publications
Latest Publications
- 1 January 2015
- Published by Elsevier in Pregnancy Hypertension
- Vol. 5 (1) , 68-69
[130-POS]
- 1 June 2013
- Published by Elsevier in European Journal of Cancer
- Vol. 49 (9) , 2199-2206
Recreational and household physical activity at different time points and DNA global methylation
- 1 June 2013
- Published by Elsevier in European Journal of Cancer
- Vol. 49 (9) , 2199-2206
Recreational and household physical activity at different time points and DNA global methylation
- Open Access
- 24 May 2013
- Published by Springer Nature in Breast Cancer Research
- Vol. 15 (3) , R42
Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort
Breast Cancer Research is the leading journal in the breast cancer field. The journal publishes research and reviews of exceptional interest covering all areas of biology and medicine relevant to breast cancer, with a special emphasis on the genetic, biochemical and cellular basis of breast cancer. As an international journal with open access to all publications the journal serves as essential reading to all researchers, clinicians, students and related healthcare professionals working in the field of breast cancer.
- 24 May 2013
- Published by Springer Nature in Breast Cancer Research
- Vol. 15 (3) , R42
Open AccessSerum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort
Breast Cancer Research is the leading journal in the breast cancer field. The journal publishes research and reviews of exceptional interest covering all areas of biology and medicine relevant to breast cancer, with a special emphasis on the genetic, biochemical and cellular basis of breast cancer. As an international journal with open access to all publications the journal serves as essential reading to all researchers, clinicians, students and related healthcare professionals working in the field of breast cancer.
- Open Access
- 30 June 2011
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 174 (4) , 390-402
Smoking Before the First Pregnancy and the Risk of Breast Cancer: A Meta-Analysis
The authors conducted a meta-analysis of the association between smoking before a first pregnancy, when undifferentiated breast tissue may be vulnerable to tobacco carcinogens, and the risk of breast cancer. A search of the published literature through August 2010 identified 23 papers reporting on associations between smoking before a first pregnancy and breast cancer. Odds ratios or hazard ratios and 95% confidence intervals, adjusted for known or suspected breast cancer risk factors, were abstracted from each study. Data were pooled using both fixed- and random-effects models. The fixed-effect summary risk ratio for breast cancer among the women who smoked before their first pregnancy versus women who had never smoked was 1.10 (95% confidence interval: 1.07, 1.14); the random-effects estimate was similar. The separate fixed-effect risk ratios for smoking only before the first pregnancy (5 studies) or only after the first pregnancy (16 studies) were both 1.07, providing no evidence that breast tissue is more susceptible to malignant transformation from smoking before the first pregnancy. While these small summary risk ratios may represent causal effects, residual confounding could readily produce estimates of this size in the absence of any causal effect.
- 30 June 2011
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 174 (4) , 390-402
Open AccessSmoking Before the First Pregnancy and the Risk of Breast Cancer: A Meta-Analysis
The authors conducted a meta-analysis of the association between smoking before a first pregnancy, when undifferentiated breast tissue may be vulnerable to tobacco carcinogens, and the risk of breast cancer. A search of the published literature through August 2010 identified 23 papers reporting on associations between smoking before a first pregnancy and breast cancer. Odds ratios or hazard ratios and 95% confidence intervals, adjusted for known or suspected breast cancer risk factors, were abstracted from each study. Data were pooled using both fixed- and random-effects models. The fixed-effect summary risk ratio for breast cancer among the women who smoked before their first pregnancy versus women who had never smoked was 1.10 (95% confidence interval: 1.07, 1.14); the random-effects estimate was similar. The separate fixed-effect risk ratios for smoking only before the first pregnancy (5 studies) or only after the first pregnancy (16 studies) were both 1.07, providing no evidence that breast tissue is more susceptible to malignant transformation from smoking before the first pregnancy. While these small summary risk ratios may represent causal effects, residual confounding could readily produce estimates of this size in the absence of any causal effect.
- 1 May 2011
- Published by Elsevier in Preventive Medicine
- Vol. 52 (5) , 394-397
Lifestyle behaviors in Black and White women with a family history of breast cancer
- 1 May 2011
- Published by Elsevier in Preventive Medicine
- Vol. 52 (5) , 394-397
Lifestyle behaviors in Black and White women with a family history of breast cancer
- 1 February 2011
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 66 (2) , 85-87
Maternal Alcohol Consumption, Alcohol Metabolism Genes, and the Risk of Oral Clefts: A Population-Based Case-Control Study in Norway, 1996–2001
Alcohol is a well-known teratogen, and previous studies have shown that the risk of oral clefts is increased by heavy maternal alcohol consumption—defined as 5 or more alcoholic drinks per sitting—during the first trimester of pregnancy. However, it is unclear whether genetic variation in maternal alcohol metabolism affects its teratogenicity. For consumption of a given level of alcohol, reduced rates of alcohol metabolism in a mother and fetus could increase the time of exposure of the fetus to higher peak levels of alcohol. The alcohol dehydrogenase 1 C (ADH1C) gene has been identified as a risk factor for cleft lip and palate independent of alcohol consumption. Previous reports have suggested that variants in the ADH1C gene may modify the association between alcohol and clefts by changing the rate of alcohol metabolism. This population-based case-control study investigated the association between oral clefts and maternal alcohol consumption among mothers and infants with ADH1C haplotypes encoding slow or fast alcohol metabolizing phenotypes. The study was conducted in Norway between 1996 and 2001; the study group included 483 Norwegian infants born with oral clefts and their mothers, and the control group was comprised of 503 structurally normal infants and their mothers, randomly selected from other live births. The level of alcohol consumption during the first 3 months of pregnancy was assessed with a self-administered, mailed questionnaire. As compared to abstaining from all alcohol use, consumption of 5 or more alcoholic drinks per sitting (binge drinking) during the first trimester of pregnancy was associated with more than twice the risk of having an infant with an oral cleft; the odds ratio (OR) was 2.6, with a 95% confidence interval (CI) of 1.4 to 4.7. This relationship was present only if either the mother or the infant carried the ADH1C variant associated with reduced alcohol metabolism (OR, 3.0; 95% CI, 1.4–6.8). There was no evidence of a relationship between maternal drinking and risk of fetal clefts if both mother and infant had only the rapid metabolism variant (OR, 0.9; 95% CI, 0.2–4.1). These findings demonstrate that the presence of slow-metabolism variants of alcohol-metabolizing genes in either the mother or fetus can substantially increase the risk of oral clefts in babies of mothers who are binge drinkers during the first trimester of pregnancy. Genetic variations in the capacity of the mother to metabolize alcohol may modify the teratogenic effects of maternal alcohol drinking.
- 1 February 2011
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 66 (2) , 85-87
Maternal Alcohol Consumption, Alcohol Metabolism Genes, and the Risk of Oral Clefts: A Population-Based Case-Control Study in Norway, 1996–2001
Alcohol is a well-known teratogen, and previous studies have shown that the risk of oral clefts is increased by heavy maternal alcohol consumption—defined as 5 or more alcoholic drinks per sitting—during the first trimester of pregnancy. However, it is unclear whether genetic variation in maternal alcohol metabolism affects its teratogenicity. For consumption of a given level of alcohol, reduced rates of alcohol metabolism in a mother and fetus could increase the time of exposure of the fetus to higher peak levels of alcohol. The alcohol dehydrogenase 1 C (ADH1C) gene has been identified as a risk factor for cleft lip and palate independent of alcohol consumption. Previous reports have suggested that variants in the ADH1C gene may modify the association between alcohol and clefts by changing the rate of alcohol metabolism. This population-based case-control study investigated the association between oral clefts and maternal alcohol consumption among mothers and infants with ADH1C haplotypes encoding slow or fast alcohol metabolizing phenotypes. The study was conducted in Norway between 1996 and 2001; the study group included 483 Norwegian infants born with oral clefts and their mothers, and the control group was comprised of 503 structurally normal infants and their mothers, randomly selected from other live births. The level of alcohol consumption during the first 3 months of pregnancy was assessed with a self-administered, mailed questionnaire. As compared to abstaining from all alcohol use, consumption of 5 or more alcoholic drinks per sitting (binge drinking) during the first trimester of pregnancy was associated with more than twice the risk of having an infant with an oral cleft; the odds ratio (OR) was 2.6, with a 95% confidence interval (CI) of 1.4 to 4.7. This relationship was present only if either the mother or the infant carried the ADH1C variant associated with reduced alcohol metabolism (OR, 3.0; 95% CI, 1.4–6.8). There was no evidence of a relationship between maternal drinking and risk of fetal clefts if both mother and infant had only the rapid metabolism variant (OR, 0.9; 95% CI, 0.2–4.1). These findings demonstrate that the presence of slow-metabolism variants of alcohol-metabolizing genes in either the mother or fetus can substantially increase the risk of oral clefts in babies of mothers who are binge drinkers during the first trimester of pregnancy. Genetic variations in the capacity of the mother to metabolize alcohol may modify the teratogenic effects of maternal alcohol drinking.
- 31 December 2010
- Published by Elsevier in Preventive Medicine
- Vol. 51 (6) , 497-501
Comparison of women's breast cancer risk factors in Geneva, Switzerland and Shanghai, China
- 31 December 2010
- Published by Elsevier in Preventive Medicine
- Vol. 51 (6) , 497-501
Comparison of women's breast cancer risk factors in Geneva, Switzerland and Shanghai, China
- 2 December 2010
- Published by Elsevier in Annals of Epidemiology
- Vol. 21 (1) , 53-55
Smoking During First Pregnancy and Breast Cancer: A Case-Control Study Using Washington State Registry Data
- 2 December 2010
- Published by Elsevier in Annals of Epidemiology
- Vol. 21 (1) , 53-55
Smoking During First Pregnancy and Breast Cancer: A Case-Control Study Using Washington State Registry Data
- Open Access
- 15 July 2008
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 168 (6) , 638-646
First-Trimester Maternal Alcohol Consumption and the Risk of Infant Oral Clefts in Norway: A Population-based Case-Control Study
Although alcohol is a recognized teratogen, evidence is limited on alcohol intake and oral cleft risk. The authors examined the association between maternal alcohol consumption and oral clefts in a national, population-based case-control study of infants born in 1996–2001 in Norway. Participants were 377 infants with cleft lip with or without cleft palate, 196 with cleft palate only, and 763 controls. Mothers reported first-trimester alcohol consumption in self-administered questionnaires completed within a few months after delivery. Logistic regression was used to calculate odds ratios and 95% confidence intervals, adjusting for confounders. Compared with nondrinkers, women who reported binge-level drinking (≥5 drinks per sitting) were more likely to have an infant with cleft lip with or without cleft palate (odds ratio = 2.2, 95% confidence interval: 1.1, 4.2) and cleft palate only (odds ratio = 2.6, 95% confidence interval: 1.2, 5.6). Odds ratios were higher among women who binged on three or more occasions: odds ratio = 3.2 for cleft lip with or without cleft palate (95% confidence interval: 1.0, 10.2) and odds ratio = 3.0 for cleft palate only (95% confidence interval: 0.7, 13.0). Maternal binge-level drinking may increase the risk of infant clefts.
- 15 July 2008
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 168 (6) , 638-646
Open AccessFirst-Trimester Maternal Alcohol Consumption and the Risk of Infant Oral Clefts in Norway: A Population-based Case-Control Study
Although alcohol is a recognized teratogen, evidence is limited on alcohol intake and oral cleft risk. The authors examined the association between maternal alcohol consumption and oral clefts in a national, population-based case-control study of infants born in 1996–2001 in Norway. Participants were 377 infants with cleft lip with or without cleft palate, 196 with cleft palate only, and 763 controls. Mothers reported first-trimester alcohol consumption in self-administered questionnaires completed within a few months after delivery. Logistic regression was used to calculate odds ratios and 95% confidence intervals, adjusting for confounders. Compared with nondrinkers, women who reported binge-level drinking (≥5 drinks per sitting) were more likely to have an infant with cleft lip with or without cleft palate (odds ratio = 2.2, 95% confidence interval: 1.1, 4.2) and cleft palate only (odds ratio = 2.6, 95% confidence interval: 1.2, 5.6). Odds ratios were higher among women who binged on three or more occasions: odds ratio = 3.2 for cleft lip with or without cleft palate (95% confidence interval: 1.0, 10.2) and odds ratio = 3.0 for cleft palate only (95% confidence interval: 0.7, 13.0). Maternal binge-level drinking may increase the risk of infant clefts.